Merck | MRK - Ordinary Share Capital


Merck reported EUR434.78M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Adidas EUR 175.36M 3.31M Mar/2026
Adyen EUR 31.54M 28.55K Dec/2025
Akzo Nobel EUR 171.31M 200K Mar/2026
Alcon AG USD 487.4M 0 Mar/2026
Amadeus IT EUR 422.35M 8.56M Mar/2026
Amarin USD 20.81M 13K Dec/2025
AstraZeneca USD 1.55B 73K Mar/2026
BASF EUR 892.52M 249.48M Sep/2025
Bayer EUR 982.42M 0 Dec/2025
Beiersdorf EUR 218.92M 1.29M Dec/2025
Covestro EUR 207.64M 18.9M Dec/2025
Danone EUR 640.17M 470.17M Dec/2025
Fresenius EUR 563.24M 0 Dec/2025
Fresenius Medical Care EUR 270.09M 9.2M Mar/2026
Genmab DKK 61.62M 52K Dec/2025
Givaudan CHF 9.23M 0 Dec/2025
GlaxoSmithKline GBP 4.05B 20.6M Mar/2026
GRIFOLS EUR 680.58M 0 Mar/2026
Henkel EUR 406.79M 7.18M Dec/2025
Hikma Pharmaceutical USD 221.89M 181.89M Dec/2025
Infineon EUR 1.3B 2.64M Mar/2026
Lakefront Biotherapeutics EUR 65.9M 0 Mar/2026
Linde USD 462.6M 1.08M Mar/2026
Lonza CHF 68.64M 0 Dec/2025
Merck EUR 434.78M 0 Mar/2026
Novartis USD 1.91B 60K Mar/2026
Philips EUR 952.02M 729K Mar/2026
Roche Holding CHF 795.62M 699.54K Dec/2025
Sanofi EUR 1.21B 8.25M Mar/2026
UCB EUR 190.36M 365.15K Dec/2025